HOPSTEM BIOTECHNOLOGY INC.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Holding
- Established
- 2017-01-16
- Employees
- 1
- Market Cap
- -
- Website
- http://www.hopstem.com
A Safety and Tolerability Study of Human Forebrain Neural Progenitor Cells Injection (hNPC01) in Subjects With Chronic Ischemic Stroke
- First Posted Date
- 2024-03-07
- Last Posted Date
- 2024-03-07
- Lead Sponsor
- Hopstem Biotechnology Inc.
- Target Recruit Count
- 21
- Registration Number
- NCT06299033
- Locations
- 🇨🇳
XiangYa Hospital, Changsha, Hunan, China
© Copyright 2025. All Rights Reserved by MedPath